Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11382979
Biodegradable lipids for the delivery of active agents
granted -
US 11382955
Long-acting VEGF inhibitors for intraocular neovascularization
granted -
US 11382932
Genetically engineered hematopoietic stem cells and uses thereof
granted -
US 11382976
Ultra-stable protein ionic liquids
granted -
US 11382929
Compositions and methods to treat disease
granted -
US 11382918
Methods for treating Huntington's Disease
granted -
US 11382899
Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery
granted -
US 11382885
Compositions for treating fungal and bacterial biofilms and methods of using the same
granted -
US 11382897
Therapeutic combination for treatment of cerebellar ataxia
granted -
US 11382880
Method for improving digestive health
granted -
US 11384337
Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 11385201
Ultra-stable protein ionic liquids
granted -
CA 3203431
PROCEDES D'AMELIORATION DE RENDEMENT MUSCULAIRE OU DE REDUCTION DE FATIGUE CHRONIQUE PAR ADMINISTRATION D'EXOSOMES DERIVES DU LAIT BOVIN
granted -
CA 3203434
PROCEDE D'AMELIORATION DE LA SANTE ARTICULAIRE PAR ADMINISTRATION D'EXOSOMES DERIVES DU LAIT DE VACHE
granted -
US 11376247
Tyrosine kinase inhibitors regenerate non-cancerous tissue after cancer therapy
granted -
US 11377646
Modified cells comprising CRISPR systems
granted -
US 11376318
Methods of preparing anti-human papillomavirus antigen t cells
granted -
US 11376273
Modulation of factor 11 expression
granted -
US 11376214
Compositions and methods for treatment of ocular diseases
granted -
US 11376346
Extracellular matrix for treating pelvic floor disorders and skeletal muscle degeneration
granted -
US 11377428
RIP1 inhibitory compounds and methods for making and using the same
granted -
US 11377478
T-cell modulatory multimeric polypeptides and methods of use thereof
granted -
US 11377491
Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancer
granted -
US 11377660
Chimeric antigen receptors targeting B-cell maturation antigen
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.